Navigation Links
Duke's Ralph Snyderman, M.D. Joins SenGenix as Senior Medical Advisor and Board Member
Date:11/12/2012

DURHAM, N.C., Nov. 12, 2012 /PRNewswire-iReach/ -- SenGenix, a private medical diagnostics company developing protein-based sensor technology for point-of-care testing, announced today that Ralph Snyderman, MD, Chancellor Emeritus of Duke University, has joined the company and will serve as senior medical advisor and a member of the Board of Directors.

Snyderman served as Chancellor for Health Affairs at Duke for 15 years and guided development of the Duke University Health System, one of the first fully integrated academic health systems in the United States.  He also served as its Chief Executive Officer.  Prior to Duke, Snyderman was Senior Vice President, medical research and development, for Genentech. He has earned numerous honors and awards during his career and has served as an advisor and board member for several companies.

"Dr. Snyderman's experience in clinical medicine, biotechnology research and industry is an exceptional asset for SenGenix in commercializing its protein engineering technologies for fast, highly accurate and low cost point-of care testing," said Lawrence Cohen, Chief Executive Officer of SenGenix.  "Dr. Snyderman's global reputation as a health system executive, clinician and researcher will help SenGenix build strong relationships with clinical investigators, physicians and hospital executives as we move forward in product development and into global market introduction."

Founded in 2012, SenGenix will commercialize protein engineering technologies to create a new platform for a menu of the most commonly ordered patient tests that can be performed in any environment -- emergency departments, operating rooms, out-patient surgical centers, physician offices, ambulances, and disaster sites.  SenGenix's technology, which was originally developed at Duke University Medical Center, uses fluorescently responsive sensors printed on test strips to provide easy, highly accurate results in seconds with just a drop of blood.  Unlike other point-of-care testing systems, no expensive sampling cartridges or reader instruments are required with SenGenix technology. 

More information about SenGenix is available at www.sengenix.com.

Media Contact: Lawrence Cohen SenGenix, Inc., 646-354-8361, lcohen@sengenix.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE SenGenix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Nutrilys Del Mar Joins Health Forces With LAPD Underwater Dive Unit
2. Keith McCormick Joins Trovagene, Inc. as Head of Commercial Operations
3. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
4. Effie Toshav Joins Fenwick - Broadens Life Sciences Service Platform
5. David F. Harty Joins Systech International as Vice President
6. Jim DuCharme Joins Prime Therapeutics as Chief Financial Officer
7. Ted Pacha Joins Pinnaclife as President of its Healthcare Distribution Division
8. Rittal Corp. Joins the HP ProActive Insight Architecture Alliance
9. Anthony Creed Joins DDSTUDIO As GM, Experience Design
10. IntelliCell Announces Dr. Arnold I. Caplan Joins Scientific Advisory Board
11. American Society of Hematology joins European Hematology Association, Patient Groups in Issuing International Call to Action to Alleviate Drug Shortages
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/2/2017)... Fenita J. Caldwell is ... Lifetime Professional in the Field of Healthcare. Caldwell ... Pharmaceuticals, AG. Her skills and areas of expertise ... Fenita ... experience as a highly successful sales specialist in ...
(Date:8/2/2017)... 2017  Life Flight Network and PeaceHealth Oregon Network announced ... care and operational efficiency for patients at hospitals in ... Cottage Grove , and Florence, Oregon ... Life Flight Network work collaboratively to move patients who require ... a time sensitive emergency exists. ...
(Date:8/1/2017)... 2017   CerSci Therapeutics , a non-opioid drug ... , has received notice from the National Institute on ... (NIH) that it has been awarded a Direct-to-Phase II ... in 2017 with an additional $1,000,000 to follow in ... application of their lead non-opioid drug candidate CT-044 to ...
Breaking Medicine Technology:
(Date:8/23/2017)... ... August 23, 2017 , ... Nightingale College continues the semiannual ... Day is a time Nightingale College dedicates to serving and volunteering for organizations that ... donations and volunteers or those that need a little extra help. , The ...
(Date:8/23/2017)... ... August 23, 2017 , ... ... has been named to the 2017 Inc. 500|5000, an exclusive ranking of America’s ... growth rate of 139 percent, marking the twelfth year that the company has ...
(Date:8/23/2017)... ... 23, 2017 , ... The non-profit Seafood Nutrition Partnership (SNP) ... of the Science Symposium in partnership with the Global Organization for EPA and ... provides a forum for global leaders in human nutrition to outline the latest ...
(Date:8/22/2017)... ... August 22, 2017 , ... Pivot ... addition of Zack Tisch as the firm’s new Consulting Services Executive. Mr. Tisch ... firm’s national accounts, from assisting clients with initial vendor selection and pre-implementation planning ...
(Date:8/22/2017)... ... August 22, 2017 , ... “To Walk Away”: a captivating ... bomber named Edward Koontz. “To Walk Away” is the creation of published author, Larry ... over two hundred manuscripts in chemistry and religion, as well as four novels. ...
Breaking Medicine News(10 mins):